Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Quan Wei

Showing results (61-70 of 350) with videos related to

Pageof 35
Sort By:
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|December 13, 2005
[Screening and identification of human nasopharyngeal carcinoma-associated antigens]Xiao-Bo Cui, Ke Xie, Chuan-Yu LiangG, et al.
World Journal of Gastroenterology|July 9, 2004
Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cellsShu-Lan Yuan, Yu-Quan Wei, Xiu-Jie Wang, et al.
Science China. Life Sciences|March 12, 2016
Establishing guidelines for CAR-T cells: challenges and considerationsWei Wang, Di-Yuan Qin, Bing-Lan Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 6, 2008
Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM methodChang-Ying Ma, Sheng-Yong Yang, Hui Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine]Kai Mei, Ling Tian, Yu-Quan Wei, et al.
Journal of Molecular Graphics & Modelling|September 13, 2008
Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2Jun Zou, Huan-Zhang Xie, Sheng-Yong Yang, et al.
Plos One|December 31, 2009
Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and AblLi-Jun Yang, Jun Zou, Huan-Zhang Xie, et al.
Biotechnology and Applied Biochemistry|March 5, 2009
CXC-chemokine-ligand-10 gene therapy efficiently inhibits the growth of cervical carcinoma on the basis of its anti-angiogenic and antiviral activityLing-lin Wang, Ping Chen, Shan Luo, et al.
Biological Research|July 22, 2009
The possible role of myosin light chain in myoblast proliferationSu-Zhen Zhang, Yong Xu, Hui-Qi Xie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2012
Enhanced gemcitabine-mediated cell killing of human lung adenocarcinoma by vector-based RNA interference against PLK1Xin-Yu Zhao, Chun-Lai Nie, Shu-Fang Liang, et al.
Pageof 35

Showing results (61-70 of 350) with videos related to

Sort By:
Pageof 35
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|December 13, 2005
[Screening and identification of human nasopharyngeal carcinoma-associated antigens]Xiao-Bo Cui, Ke Xie, Chuan-Yu LiangG, et al.
World Journal of Gastroenterology|July 9, 2004
Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cellsShu-Lan Yuan, Yu-Quan Wei, Xiu-Jie Wang, et al.
Science China. Life Sciences|March 12, 2016
Establishing guidelines for CAR-T cells: challenges and considerationsWei Wang, Di-Yuan Qin, Bing-Lan Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 6, 2008
Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM methodChang-Ying Ma, Sheng-Yong Yang, Hui Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine]Kai Mei, Ling Tian, Yu-Quan Wei, et al.
Journal of Molecular Graphics & Modelling|September 13, 2008
Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2Jun Zou, Huan-Zhang Xie, Sheng-Yong Yang, et al.
Plos One|December 31, 2009
Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and AblLi-Jun Yang, Jun Zou, Huan-Zhang Xie, et al.
Biotechnology and Applied Biochemistry|March 5, 2009
CXC-chemokine-ligand-10 gene therapy efficiently inhibits the growth of cervical carcinoma on the basis of its anti-angiogenic and antiviral activityLing-lin Wang, Ping Chen, Shan Luo, et al.
Biological Research|July 22, 2009
The possible role of myosin light chain in myoblast proliferationSu-Zhen Zhang, Yong Xu, Hui-Qi Xie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2012
Enhanced gemcitabine-mediated cell killing of human lung adenocarcinoma by vector-based RNA interference against PLK1Xin-Yu Zhao, Chun-Lai Nie, Shu-Fang Liang, et al.
Pageof 35